Profusa PFSA 深 滬
等待開盤 08-21 09:30:00 美东时间
7.57
-6.000
-44.22%
華盛通- 最 高13.00
- 今 開12.92
- 成交量 117.63万股
- 最 低 7.11
- 昨 收 13.57
- 總市值 1834.14万
- 52周最高 4500.00
- 市盈率 靜 --
- 換手率 48.55%
- 52周最低 3.2228
- 委 比 25.65%
- 總股本 242.29万
- 歷史最高 18000.00
- 量 比 0.10
- 振 幅 43.40%
- 歷史最低 7.11
- 每 手 1
- 風險率 1022.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profusa, Inc. reports Q2 results
Profusa, Inc. press release (PFSA): Q2 Cash on hand at June 30, 2026 was $719,000. Total assets were $1.0 million. Current liabilities and total liabilities were $28.2 million. Net loss for the three ...
今天 03:10
Profusa Q2 EPS $(151.80) Up From $(9.10 thousand) YoY
Profusa (NASDAQ:PFSA) reported quarterly losses of $(151.80) per share. This is a 98.33 percent increase over losses of $(9.10 thousand) per share from the same period last year.
08-20 20:53
Why Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Flexsteel Industries Inc (NASDAQ:FLXS) rose sharply in pre-market trading as the company posted better-than-expected fourth-quarter financial results. The company reported quarterly earnings of $1.33 per share, which beat the analyst consensus estimate of $1.09 per share. The company repor...
08-18 17:01
Why Is Profusa Stock Falling Monday?
Profusa Inc. (NASDAQ:PFSA) stock fell in Monday premarket trading after the company announced leadership changes and signed a non-binding acquisition term sheet. PFSA has lost about 99.95% of its value over the past 12 months. Diagnostics Acquisition Term Sheet Profusa signed a non-binding term shee...
07-27 19:46
11 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's regular session. The market value of their outstanding shares is at $12.2 million. Liminatus Pharma (NASDAQ:LIMN) shares rose 26.04% to $0.14. The market value of their outstanding shares is at $5.8 milli...
07-03 01:05
Profuse Announces 1-For-25 Reverse Stock Split, Effective July 7
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed an amendment to its amended and restated certificate of...
07-02 23:03
Profusa Shareholders Approve Proposed Acquisition Of PanOmics Multi-Omics Diagnostics Platform, Debt-Conversion To Enhance Balance Sheet, And Approval Of Reverse Stock Split
Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented at the Company’s 2026 Annual Meeting of Shareholders held on June 23, 2026.
06-24 20:03
Profusa To Trade On Nasdaq Capital Market, Effective May 15
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, announces
05-15 19:32
Profusa Initiates Board-Led Process To Evaluate Strategic Alternatives Intended To Maximize Shareholder Value And Support Commercial, Regulatory And Platform-Expansion Initiatives
Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunitiesProcess intended to evaluate strategic growth alternatives to enhance scale, strengthen
05-05 20:34
Why Bed Bath & Beyond Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
Shares of Bed Bath & Beyond (BBBY) rose 23.4% in pre-market trading after beating revenue estimates. KIDZ, CLDI, DRCT, PFSA, KFRC, MLEC, SANM, SEI, DT are also up while VISN, ERAS, AREB, and YAAS are down.
04-28 17:11
